Suppr超能文献

经肛门与非经肛门手术治疗原发性直肠胃肠道间质瘤:一家大型中心的10年经验

Transanal versus nontransanal surgery for the treatment of primary rectal gastrointestinal stromal tumors: a 10-year experience in a high-volume center.

作者信息

Yang Zifeng, Guo Wentai, Huang Rongkang, Hu Minhui, Wang Huaiming, Wang Hui

机构信息

Department of Colorectal Surgery, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou 510655, China.

Guangdong Institute of Gastroenterology, Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, Supported by National Key Clinical Discipline, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou 510655, China.

出版信息

Ann Transl Med. 2020 Mar;8(5):201. doi: 10.21037/atm.2020.01.55.

Abstract

BACKGROUND

Rectal gastrointestinal stromal tumor (GIST) is a rare digestive disease that has a distinct malignant tendency compared to that of gastric-derived GIST. At present, there is still no standard, and the surgical approach to rectal GIST is controversial.

METHODS

The clinicopathological data and prognosis of rectal GIST patients admitted to the Sixth Affiliated Hospital of Sun Yat-sen University from 1998.01.01 to 2018.12.31 were collected retrospectively. All cases were divided into either the transanal (TA) group or the nontransanal (NTA) group.

RESULTS

A total of 537 GIST cases were treated in 10 years, including 82 rectal GIST cases (64 cases underwent surgical resection, including 29 cases in the TA group and 35 cases in the NTA group). Preoperative neoadjuvant therapy (P=0.003), postoperative adjuvant therapy (P=0.017), operative time (P=0.013), blood loss (P=0.038), anus-preserver (P=0.048), 30-day complication rate (P=0.000), time to flatus (P=0.036), hospital stays (P=0.011), distance from the anus (P=0.047), tumor size (P=0.002), mitotic count (P=0.035) and National Institutes of Health (NIH) criteria (P=0.000) were significantly different between these two groups (all P<0.05). The median follow-up time was 41 (range, 1-122) months. Twelve patients had recurrence and metastasis, and 4 patients died. The 5-year disease-free survival (DFS) and overall survival (OS) were 74.4% and 91.2%, respectively, in the whole group. There were no statistically significant differences between the TA group and the NTA group at 5-year DFS (81.3% . 79.0%, P=0.243) and OS (88.7% . 93.3%, P=0.308).

CONCLUSIONS

In the treatment of rectal GIST, TA resection has a minimally invasive effect, less postoperative complications, high anal sphincter preservation rate, and R0 resection rate and a better prognosis. How to improve the proportion of neoadjuvant therapy and choose the appropriate cases for TA surgery is still a challenge.

摘要

背景

直肠胃肠道间质瘤(GIST)是一种罕见的消化系统疾病,与胃源性GIST相比,具有明显的恶性倾向。目前,尚无标准,直肠GIST的手术方式存在争议。

方法

回顾性收集1998年1月1日至2018年12月31日在中山大学附属第六医院住院的直肠GIST患者的临床病理资料及预后情况。所有病例分为经肛门(TA)组和非经肛门(NTA)组。

结果

10年间共治疗537例GIST病例,其中直肠GIST 82例(64例行手术切除,TA组29例,NTA组35例)。两组术前新辅助治疗(P = 0.003)、术后辅助治疗(P = 0.017)、手术时间(P = 0.013)、失血量(P = 0.038)、保肛情况(P = 0.048)、30天并发症发生率(P = 0.000)、排气时间(P = 0.036)、住院时间(P = 0.011)、距肛门距离(P = 0.047)、肿瘤大小(P = 0.002)、核分裂象计数(P = 0.035)及美国国立卫生研究院(NIH)标准(P = 0.0(0))差异均有统计学意义(均P < 0.05)。中位随访时间为41(范围1 - 122)个月。12例患者出现复发转移,4例死亡。全组5年无病生存率(DFS)和总生存率(OS)分别为74.4%和91.2%。TA组与NTA组在5年DFS(81.3%对79.0%,P = 0.243)和OS(88.7%对93.3%,P = 0.308)方面差异无统计学意义。

结论

在直肠GIST的治疗中,TA切除具有微创效果、术后并发症少、肛门括约肌保留率高、R0切除率高及预后较好等优点。如何提高新辅助治疗比例及选择合适病例行TA手术仍是一项挑战。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4cc/7154442/9b08ef2a724e/atm-08-05-201-f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验